Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Active Noninfectious Uveitis Affecting the Posterior Segment: early-phase trial registry
1 of 1 indexed Active Noninfectious Uveitis Affecting the Posterior Segment trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
Active Noninfectious Uveitis Affecting the Posterior Segment: 1 US clinical trial tracked, 1 recruiting.
Active Noninfectious Uveitis Affecting the Posterior Segment is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Regeneron Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition active-noninfectious-uveitis-affecting-the-posterior-segment
OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Active Noninfectious Uveitis Affecting the Posterior Segment lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Active Noninfectious Uveitis Affecting the Posterior Segment on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Active Noninfectious Uveitis Affecting the Posterior Segment is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Active Noninfectious Uveitis Affecting the Posterior Segment records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Active Noninfectious Uveitis Affecting the Posterior Segment trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Active Noninfectious Uveitis Affecting the Posterior Segment page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Active Noninfectious Uveitis Affecting the Posterior Segment trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Regeneron Pharmaceuticals sponsors the most Active Noninfectious Uveitis Affecting the Posterior Segment trials on record, review their full trial history before evaluating a specific study. See Regeneron Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Active Noninfectious Uveitis Affecting the Posterior Segment condition card totals 1 registered trials; most-linked intervention REGN7041; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.